{"title":"The Misdiagnosis and Underdiagnosis of Hepatic Encephalopathy.","authors":"Patricia P Bloom","doi":"10.14309/ctg.0000000000000784","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Patients with cirrhosis are at risk of developing hepatic encephalopathy, which can present with a wide range of symptoms, including confusion, lethargy, inappropriate behavior, and altered sleep patterns. In addition to hepatic encephalopathy, patients with cirrhosis are at risk of developing mild cognitive impairment, dementia, and delirium, which have features closely resembling hepatic encephalopathy. Given the similar presentation of these conditions, misdiagnosis can and does occur. Mild cognitive impairment is common in individuals aged ≥50 years and can progress to dementia in those affected. Dementia and hepatic encephalopathy are both characterized by sleep disturbance and cognitive dysfunction, thus differentiating these conditions can be difficult. Furthermore, delirium can disrupt sleep patterns, and liver disease is recognized as a risk factor for its development. As hepatic encephalopathy is a cirrhosis-related complication, determining if a patient has undiagnosed cirrhosis is critical, particularly given the large number of patients with asymptomatic, compensated cirrhosis. Separately, underdiagnosis of minimal hepatic encephalopathy can occur even in patients with diagnosed liver disease, related, in part, to lack of testing. Given the availability of effective therapies available for managing symptoms and preventing future episodes, accurate diagnosis of hepatic encephalopathy is essential.</p>","PeriodicalId":10278,"journal":{"name":"Clinical and Translational Gastroenterology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14309/ctg.0000000000000784","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Patients with cirrhosis are at risk of developing hepatic encephalopathy, which can present with a wide range of symptoms, including confusion, lethargy, inappropriate behavior, and altered sleep patterns. In addition to hepatic encephalopathy, patients with cirrhosis are at risk of developing mild cognitive impairment, dementia, and delirium, which have features closely resembling hepatic encephalopathy. Given the similar presentation of these conditions, misdiagnosis can and does occur. Mild cognitive impairment is common in individuals aged ≥50 years and can progress to dementia in those affected. Dementia and hepatic encephalopathy are both characterized by sleep disturbance and cognitive dysfunction, thus differentiating these conditions can be difficult. Furthermore, delirium can disrupt sleep patterns, and liver disease is recognized as a risk factor for its development. As hepatic encephalopathy is a cirrhosis-related complication, determining if a patient has undiagnosed cirrhosis is critical, particularly given the large number of patients with asymptomatic, compensated cirrhosis. Separately, underdiagnosis of minimal hepatic encephalopathy can occur even in patients with diagnosed liver disease, related, in part, to lack of testing. Given the availability of effective therapies available for managing symptoms and preventing future episodes, accurate diagnosis of hepatic encephalopathy is essential.
期刊介绍:
Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a peer-reviewed open access online journal dedicated to innovative clinical work in the field of gastroenterology and hepatology. CTG hopes to fulfill an unmet need for clinicians and scientists by welcoming novel cohort studies, early-phase clinical trials, qualitative and quantitative epidemiologic research, hypothesis-generating research, studies of novel mechanisms and methodologies including public health interventions, and integration of approaches across organs and disciplines. CTG also welcomes hypothesis-generating small studies, methods papers, and translational research with clear applications to human physiology or disease.
Colon and small bowel
Endoscopy and novel diagnostics
Esophagus
Functional GI disorders
Immunology of the GI tract
Microbiology of the GI tract
Inflammatory bowel disease
Pancreas and biliary tract
Liver
Pathology
Pediatrics
Preventative medicine
Nutrition/obesity
Stomach.